Palisade Capital Management’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-680,422
| Closed | -$9.55M | – | 454 |
|
|
2017
Q1 | $9.55M | Buy |
680,422
+25,110
| +4% | +$352K | 0.37% | 84 |
|
|
2016
Q4 | $12.3M | Sell |
655,312
-13,085
| -2% | -$245K | 0.46% | 68 |
|
|
2016
Q3 | $11M | Sell |
668,397
-5,232
| -0.8% | -$86.4K | 0.39% | 75 |
|
|
2016
Q2 | $9.05M | Sell |
673,629
-30,721
| -4% | -$413K | 0.33% | 90 |
|
|
2016
Q1 | $10.8M | Buy |
704,350
+147,102
| +26% | +$2.25M | 0.35% | 88 |
|
|
2015
Q4 | $11.1M | Buy |
557,248
+172,191
| +45% | +$3.42M | 0.36% | 86 |
|
|
2015
Q3 | $6.71M | Buy |
385,057
+154,822
| +67% | +$2.7M | 0.2% | 183 |
|
|
2015
Q2 | $4.66M | Buy |
+230,235
| New | +$4.66M | 0.12% | 276 |
|